<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>METHOCARBAMOL- methocarbamol tablet </strong><br>Solco Healthcare US LLC<br></p></div>
<h1>Methocarbamol Tablets, USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">R<span class="Italics">x</span> only <br> Solco Healthcare U.S., LLC</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s1"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Methocarbamol tablets, USP, a carbamate derivative of guaifenesin, are a central nervous system (CNS) depressant with sedative and musculoskeletal relaxant properties.</p>
<p>The chemical name of methocarbamol is 3-(2-meth-oxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C<span class="Sub">11</span>H<span class="Sub">15</span>NO<span class="Sub">5</span>. Its molecular weight is 241.24. The structural formula is shown below.</p>
<div class="Figure"><img alt="Methocarbamol Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=32863f21-30ff-4a8b-a2e6-8ab14a37af0d&amp;name=8abf52d1-f208-4ba0-821c-8417308a985a-01.jpg"></div>
<p>Methocarbamol is a white powder, sparingly soluble in water and chloroform, soluble in alcohol (only with heating) and propylene glycol, and insoluble in benzene and <span class="Italics">n</span>-hexane.</p>
<p>Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets for oral administration. Methocarbamol tablets, USP 500 mg and 750 mg contain the following inactive ingredients: povidone, sodium starch glycolate and magnesium stearate.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="s2"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">The mechanism of action of methocarbamol in humans has not been established, but may be due to general central nervous system (CNS) <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>. It has no direct action on the contractile mechanism of striated muscle, the motor end plate or the nerve fiber.</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="s2.1"></a><a name="section-4"></a><p></p>
<h1>Pharmacokinetics</h1>
<p class="First">In healthy volunteers, the plasma clearance of methocarbamol ranges between 0.20 and 0.80 L/h/kg, the mean plasma elimination half-life ranges between 1 and 2 hours, and the plasma protein binding ranges between 46% and 50%. </p>
<p>Methocarbamol is metabolized via dealkylation and hydroxylation. Conjugation of methocarbamol also is likely. Essentially all methocarbamol metabolites are eliminated in the urine. Small amounts of unchanged methocarbamol also are excreted in the urine.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s2.2"></a><a name="section-5"></a><p></p>
<h1>Special populations</h1>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s2.3"></a><a name="section-6"></a><p></p>
<h1>Elderly</h1>
<p class="First">The mean (± SD) elimination half-life of methocarbamol in elderly healthy volunteers (mean (± SD) age, 69 (± 4) years) was slightly prolonged compared to a younger (mean (± SD) age, 53.3 (± 8.8) years), healthy population (1.5 (± 0.4) hours versus 1.1 (± 0.27) hours, respectively). The fraction of bound methocarbamol was slightly decreased in the elderly versus younger volunteers (41 to 43% versus 46 to 50%, respectively).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s2.4"></a><a name="section-7"></a><p></p>
<h1>Renally impaired</h1>
<p class="First">The clearance of methocarbamol in 8 renally-impaired patients on maintenance hemodialysis was reduced about 40% compared to 17 normal subjects, although the mean (± SD) elimination half-life in these two groups was similar: 1.2 (± 0.6) versus 1.1 (± 0.3) hours, respectively.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s2.5"></a><a name="section-8"></a><p></p>
<h1>Hepatically impaired</h1>
<p class="First">In 8 patients with cirrhosis secondary to <span class="product-label-link" type="condition" conceptid="433753" conceptname="Alcohol abuse">alcohol abuse</span>, the mean total clearance of methocarbamol was reduced approximately 70% compared to that obtained in 8 age- and weight-matched normal subjects. The mean (± SD) elimination half-life in the cirrhotic patients and the normal subjects was 3.38 (± 1.62) hours and 1.11 (± 0.27) hours, respectively.The percent of methocarbamol bound to plasma proteins was decreased to approximately 40 to 45% compared to 46 to 50% in the normal subjects.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s3"></a><a name="section-9"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax <span class="product-label-link" type="condition" conceptid="4136244" conceptname="Feeling tense">tense</span> skeletal muscles in man.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s4"></a><a name="section-10"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Methocarbamol tablets, USP are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="s5"></a><a name="section-11"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Since methocarbamol may possess a general CNS depressant effect, patients receiving Methocarbamol tablets, USP should be cautioned about combined effects with alcohol and other CNS depressants.</p>
<p>Safe use of Methocarbamol tablets, USP has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, Methocarbamol tablets, USP should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards (see <span class="Bold"><a href="#s6">Precautions, </a><a href="#s10">Pregnancy</a></span>).</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s5.1"></a><a name="section-11.1"></a><p></p>
<h2>Use In Activities Requiring Mental Alertness </h2>
<p class="First">Methocarbamol may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle. Patients should be cautioned about operating machinery, including automobiles, until they are reasonably certain that methocarbamol therapy does not adversely affect their ability to engage in such activities.</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="s6"></a><a name="section-12"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_0275f7ca-17ed-4ca5-8627-8517e53b450d"></a><a name="section-12.1"></a><p></p>
<h2>Information for patients</h2>
<p class="First">Patients should be cautioned that methocarbamol may cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, which may impair their ability to operate motor vehicles or machinery.</p>
<p>Because methocarbamol may possess a general CNS-depressant effect, patients should be cautioned about combined effects with alcohol and other CNS depressants.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="s7"></a><a name="section-12.2"></a><p></p>
<h2>Drug interactions</h2>
<p class="First">See <span class="Bold"><a href="#s5">Warnings</a></span> and <span class="Bold"><a href="#s6">Precautions</a></span> for interaction with CNS drugs and alcohol. </p>
<p>Methocarbamol may inhibit the effect of pyridostigmine bromide. Therefore, methocarbamol should be used with caution in patients with <span class="product-label-link" type="condition" conceptid="76685" conceptname="Myasthenia gravis">myasthenia gravis</span> receiving anticholinesterase agents.</p>
</div>
<div class="Section" data-sectionCode="34074-5">
<a name="s8"></a><a name="section-12.3"></a><p></p>
<h2>Drug/laboratory test interactions</h2>
<p class="First">Methocarbamol may cause a color interference in certain screening tests for 5-hydroxyindoleacetic acid (5-HIAA) using nitrosonaphthol reagent and in screening tests for urinary vanillylmandelic acid (VMA) using the Gitlow method.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="s9"></a><a name="section-12.4"></a><p></p>
<h2>Carcinogenesis, mutagenesis, impairment of fertility</h2>
<p class="First">Long-term studies to evaluate the carcinogenic potential of methocarbamol have not been performed. No studies have been conducted to assess the effect of methocarbamol on mutagenesis or its potential to impair fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="s10"></a><a name="section-12.5"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="s10.1"></a><a name="section-12.5.1"></a><p></p>
<h3 class="Bold">Teratogenic effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="s10.2"></a><a name="section-12.5.1.1"></a><p></p>
<h4 class="Italics">Pregnancy Category C</h4>
<p class="First">Animal reproduction studies have not been conducted with methocarbamol. It is also not known whether methocarbamol can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Methocarbamol tablets, USP should be given to a pregnant woman only if clearly needed.</p>
<p>Safe use of Methocarbamol tablets, USP has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, Methocarbamol tablets, USP should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards (see <span class="Bold"><a href="#s5">Warnings</a></span>). </p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="s11"></a><a name="section-12.5.2"></a><p></p>
<h3 class="Bold">Nursing mothers</h3>
<p class="First">Methocarbamol and/or its metabolites are excreted in the milk of dogs; however, it is not known whether methocarbamol or its metabolites are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Methocarbamol tablets, USP are administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="s12"></a><a name="section-12.5.3"></a><p></p>
<h3 class="Bold">Pediatric use</h3>
<p class="First">Safety and effectiveness of Methocarbamol tablets, USP in pediatric patients below the age of 16 have not been established.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s13"></a><a name="section-13"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Adverse reactions reported coincident with the administration of methocarbamol include:</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s13.1"></a><a name="section-13.1"></a><p></p>
<h2>Body as a whole:</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">Anaphylactic reaction</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioneurotic edema</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13.2"></a><a name="section-13.2"></a><p></p>
<h2>Cardiovascular system:</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">Bradycardia</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span>, <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13.3"></a><a name="section-13.3"></a><p></p>
<h2>Digestive system:</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">Dyspepsia</span>, <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span> (including <span class="product-label-link" type="condition" conceptid="4185719" conceptname="Cholestatic jaundice syndrome">cholestatic jaundice</span>), <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13.4"></a><a name="section-13.4"></a><p></p>
<h2>Hemic and lymphatic system:</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">Leukopenia</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13.5"></a><a name="section-13.5"></a><p></p>
<h2 class="Bold">Immune system:</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13.6"></a><a name="section-13.6"></a><p></p>
<h2>Nervous system:</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="439147" conceptname="Amnesia">Amnesia</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, <span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">diplopia</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span> or <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">lightheadedness</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, mild <span class="product-label-link" type="condition" conceptid="441417" conceptname="Incoordination">muscular incoordination</span>, <span class="product-label-link" type="condition" conceptid="378165" conceptname="Nystagmus">nystagmus</span>, sedation, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> (including <span class="product-label-link" type="condition" conceptid="374924" conceptname="Generalized convulsive epilepsy">grand mal</span>), <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span></p>
<br>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13.7"></a><a name="section-13.7"></a><p></p>
<h2>Skin and special senses:</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">Blurred vision</span>, <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal congestion</span>, metallic taste, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span></p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-14"></a><p></p>
<p class="First"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Solco Healthcare at  1-888-869-8008 or FDA at 1-800-FDA-1088 or <span class="Italics"> www.fda.gov/medwatch.</span></span></p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="s14"></a><a name="section-15"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Limited information is available on the acute toxicity of methocarbamol. <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">Overdose</span> of methocarbamol is frequently in conjunction with alcohol or other CNS depressants and includes the following symptoms: <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, and <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>.</p>
<p>In post-marketing experience, <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">deaths</span> have been reported with an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> of methocarbamol alone or in the presence of other CNS depressants, alcohol or psychotropic drugs.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s14.1"></a><a name="section-15.1"></a><p></p>
<h2>Treatment </h2>
<p class="First">Management of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of hemodialysis in managing <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> is unknown.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s15"></a><a name="section-16"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Methocarbamol tablets, USP, 500 mg – Adults:</p>
<p>Initial dosage: 3 tablets q.i.d.</p>
<p>Maintenance dosage: 2 tablets q.i.d.</p>
<br><p>Methocarbamol tablets, USP: 750 mg – Adults:</p>
<p>Initial dosage: 2 tablets q.i.d.</p>
<p>Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d.</p>
<p>Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s16"></a><a name="section-17"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Methocarbamol tablets, USP</p>
<p>500 mg tablets are round standard concave, scored, white to off-white tablet, debossed S 225 on one side and plain on the reverse side.</p>
<p>They are supplied as follows:</p>
<p>Bottles of 100 NDC 43547-225-10<br> Bottles of 500 NDC 43547-225-50</p>
<br><p>Methocarbamol tablets, USP</p>
<p>750 mg tablets are modified capsule shape, white to off-white tablet, debossed S 226 on one side and plain on the reverse side.</p>
<p>They are supplied as follows:</p>
<p>Bottles of 100 NDC 43547-226-10<br>Bottles of 500 NDC 43547-226-50</p>
<div class="Section" data-sectionCode="44425-7">
<a name="i4i_storage_id_bfda344a-1258-4c0b-8060-4f4cfc70f43f"></a><a name="section-17.1"></a><p></p>
<p class="First"><span class="Bold">Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F).<br> [see USP Controlled Room Temperature].<br>Dispense in tight container.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s17"></a><a name="section-18"></a><p></p>
<p class="First">Manufactured for:</p>
<p><span class="Bold">Solco <br> Healthcare U.S.</span></p>
<p>Solco Healthcare U.S., LLC <br>Cranbury, NJ 08512</p>
<p>Manufactured by: <br> Emcure Pharmaceuticals USA Inc. <br> 21-B, Cotters Lane <br> East Brunswick, NJ 08816</p>
<p>M.F. # 0301-01<br> Rev. October 2012.</p>
<p><span class="Bold">R</span><span class="Bold Italics">x</span><span class="Bold"> only</span></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-19"></a><p></p>
<h1>500 mg Label</h1>
<p class="First">NDC 43547-225-10       <span class="Bold">R<span class="Bold Italics">x</span><span class="Bold"> only</span></span></p>
<p><span class="Bold">Methocarbamol <br> Tablets, USP</span></p>
<p><span class="Bold">500 mg</span></p>
<p><span class="Bold">Solco <br>Healthcare U.S.      100 Tablets </span></p>
<div class="Figure"><img alt="Methocarbamol 500 mg Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=32863f21-30ff-4a8b-a2e6-8ab14a37af0d&amp;name=8abf52d1-f208-4ba0-821c-8417308a985a-02.jpg"></div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-20"></a><p></p>
<h1>750 mg Label</h1>
<p class="First">NDC 43547-226-10       <span class="Bold">R<span class="Bold Italics">x</span><span class="Bold"> only</span></span></p>
<p><span class="Bold">Methocarbamol <br> Tablets, USP</span></p>
<p><span class="Bold">750 mg</span></p>
<p><span class="Bold">Solco <br>Healthcare U.S.      100 Tablets </span></p>
<div class="Figure"><img alt="Methocarbamol 750 mg Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=32863f21-30ff-4a8b-a2e6-8ab14a37af0d&amp;name=8abf52d1-f208-4ba0-821c-8417308a985a-03.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>METHOCARBAMOL 		
					</strong><br><span class="contentTableReg">methocarbamol tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:43547-225</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>METHOCARBAMOL</strong> (METHOCARBAMOL) </td>
<td class="formItem">METHOCARBAMOL</td>
<td class="formItem">500 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POVIDONE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (white to off-white) </td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">11mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">S225</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:43547-225-50</td>
<td class="formItem">500  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:43547-225-10</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA086989</td>
<td class="formItem">01/15/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>METHOCARBAMOL 		
					</strong><br><span class="contentTableReg">methocarbamol tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:43547-226</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>METHOCARBAMOL</strong> (METHOCARBAMOL) </td>
<td class="formItem">METHOCARBAMOL</td>
<td class="formItem">750 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POVIDONE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (white to off-white) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE (capsule-shaped) </td>
<td class="formLabel">Size</td>
<td class="formItem">18mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">S226</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:43547-226-50</td>
<td class="formItem">500  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:43547-226-10</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA086988</td>
<td class="formItem">01/15/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Solco Healthcare US LLC
							(828343017)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 1/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>8abf52d1-f208-4ba0-821c-8417308a985a</div>
<div>Set id: 32863f21-30ff-4a8b-a2e6-8ab14a37af0d</div>
<div>Version: 2</div>
<div>Effective Time: 20130117</div>
</div>
</div> <div class="DistributorName">Solco Healthcare US LLC</div></p>
</body></html>
